Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: While we concur with Dr Miller
and colleagues1 that the evidence for making
practice and public health decisions in CAM should come from large, double-blind,
randomized controlled trials (RCTs), we believe there are 2 key ethical issues
in CAM research that the authors should have addressed. First, who determines
the "social value" of CAM research? Second, use of the terms "placebo" and
"non-specific" ignores the complexity of clinical responses found when delivering
therapies in a rich and meaningful context.
Jonas WB, Goertz C, Ives J, Chez RA, Walach H. Ethical Issues in Research in Complementary and Alternative Medicine. JAMA. 2004;291(18):2192-2194. doi:10.1001/jama.291.18.2192-b